Free Trial

Tristel plc (LON:TSTL) Increases Dividend to GBX 8.28 Per Share

Tristel logo with Medical background

Tristel plc (LON:TSTL - Get Free Report) announced a dividend on Monday, October 21st, Upcoming.Co.Uk reports. Shareholders of record on Thursday, November 28th will be paid a dividend of GBX 8.28 ($0.11) per share on Friday, December 20th. This represents a yield of 2.1%. The ex-dividend date of this dividend is Thursday, November 28th. This is a boost from Tristel's previous dividend of $5.24. The official announcement can be seen at this link.

Tristel Stock Performance

TSTL stock traded down GBX 7.50 ($0.10) during trading on Monday, hitting GBX 387.50 ($5.03). 308,796 shares of the company traded hands, compared to its average volume of 62,644. Tristel has a 1 year low of GBX 346 ($4.49) and a 1 year high of GBX 510 ($6.62). The company has a market cap of £184.64 million, a PE ratio of 2,961.54 and a beta of 0.23. The stock's 50-day simple moving average is GBX 426.46 and its 200 day simple moving average is GBX 445.55. The company has a debt-to-equity ratio of 19.12, a current ratio of 4.92 and a quick ratio of 3.83.

Insider Activity

In other news, insider Elizabeth Dixon sold 50,000 shares of the stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.15), for a total transaction of £198,500 ($257,725.27). Insiders own 4.89% of the company's stock.

About Tristel

(Get Free Report)

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.

Read More

Dividend History for Tristel (LON:TSTL)

Should you invest $1,000 in Tristel right now?

Before you consider Tristel, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.

While Tristel currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Energy Vault’s 100% Stock Jump: CEO Discusses $350M Project in Australia in MarketBeat CEO Series
Market Shifts After Election: What Stocks Could Benefit Most?
Post-Election Chaos or Opportunity? Prepare Your Investments

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines